Stalmeier PF - Search Results

1

[Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff].

Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ. Lamers LM, et al. Among authors: stalmeier pf. Ned Tijdschr Geneeskd. 2005 Jul 9;149(28):1574-8. Ned Tijdschr Geneeskd. 2005. PMID: 16038162 Dutch.

2

Inconsistencies in TTO and VAS values for EQ-5D health states.

Lamers LM, Stalmeier PF, Krabbe PF, Busschbach JJ. Lamers LM, et al. Among authors: stalmeier pf. Med Decis Making. 2006 Mar-Apr;26(2):173-81. doi: 10.1177/0272989X06286480. Med Decis Making. 2006. PMID: 16525171

3

The Dutch tariff: results and arguments for an effective design for national EQ-5D valuation studies.

Lamers LM, McDonnell J, Stalmeier PF, Krabbe PF, Busschbach JJ. Lamers LM, et al. Among authors: stalmeier pf. Health Econ. 2006 Oct;15(10):1121-32. doi: 10.1002/hec.1124. Health Econ. 2006. PMID: 16786549

4

Testing the interval-level measurement property of multi-item visual analogue scales.

Krabbe PF, Stalmeier PF, Lamers LM, Busschbach JJ. Krabbe PF, et al. Among authors: stalmeier pf. Qual Life Res. 2006 Dec;15(10):1651-61. doi: 10.1007/s11136-006-0027-7. Epub 2006 Sep 20. Qual Life Res. 2006. PMID: 17031501

5

On the assessment of preferences for health and duration: maximal endurable time and better than dead preferences.

Stalmeier PF, Lamers LM, Busschbach JJ, Krabbe PF. Stalmeier PF, et al. Med Care. 2007 Sep;45(9):835-41. doi: 10.1097/MLR.0b013e3180ca9ac5. Med Care. 2007. PMID: 17712253

6

The gap effect: discontinuities of preferences around dead.

Stalmeier PF, Busschbach JJ, Lamers LM, Krabbe PF. Stalmeier PF, et al. Health Econ. 2005 Jul;14(7):679-85. doi: 10.1002/hec.986. Health Econ. 2005. PMID: 15744750

7

Values for health states with different life durations.

Scalone L, Stalmeier PF, Milani S, Krabbe PF. Scalone L, et al. Among authors: stalmeier pf. Eur J Health Econ. 2015 Dec;16(9):917-25. doi: 10.1007/s10198-014-0634-0. Epub 2014 Sep 30. Eur J Health Econ. 2015. PMID: 25266301

8

Health-state valuations have been core issues in the field of medical decision making.

Krabbe PF, Adang EM, Stalmeier PF. Krabbe PF, et al. Among authors: stalmeier pf. Med Decis Making. 2003 Nov-Dec;23(6):542; author reply 543. doi: 10.1177/0272989X03236010. Med Decis Making. 2003. PMID: 14672114 No abstract available.

9

[The patient chooses for feasibility and effectiveness].

Stalmeier PF, van Tol-Geerdink JJ, van Lin EN, Schimmel E, Huizenga H, van Daal WA, Leer JW. Stalmeier PF, et al. Ned Tijdschr Geneeskd. 2009 Mar 28;153(13):600-6. Ned Tijdschr Geneeskd. 2009. PMID: 19408536 Clinical Trial. Dutch. No abstract available.

10

In a Child's Shoes: Composite Time Trade-Off Valuations for EQ-5D-Y-3L with Different Proxy Perspectives.

Lipman SA, Essers BAB, Finch AP, Sajjad A, Stalmeier PFM, Roudijk B. Lipman SA, et al. Among authors: stalmeier pfm. Pharmacoeconomics. 2022 Dec;40(Suppl 2):181-192. doi: 10.1007/s40273-022-01202-1. Epub 2022 Oct 18. Pharmacoeconomics. 2022. PMID: 36255560 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page